Kabashima, K., Saji, T., Murata, T., Nagamachi, M., Matsuoka, T., Segi, E., . . . Narumiya, S. (2002). The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut. American Society for Clinical Investigation.
Chicago Style CitationKabashima, Kenji, et al. The Prostaglandin Receptor EP4 Suppresses Colitis, Mucosal Damage and CD4 Cell Activation in the Gut. American Society for Clinical Investigation, 2002.
Cita MLAKabashima, Kenji, et al. The Prostaglandin Receptor EP4 Suppresses Colitis, Mucosal Damage and CD4 Cell Activation in the Gut. American Society for Clinical Investigation, 2002.
Atenció: Aquestes cites poden no estar 100% correctes.